TEVA

Neutral

Teva to Present at the BofA Securities Health Care Conference

Teva Pharmaceutical Industries Ltd. announced that Eric Hughes, EVP of Global R&D & Chief Medical Officer, will present at the BofA Securities Health ...

GlobeNewswire 1 week ago 0

Neutral

Is It Too Late To Reassess Teva (TEVA) After Its 118.5% One-Year Surge?

Teva Pharmaceutical Industries has seen a significant 118.5% surge over the past year, prompting an assessment of its current valuation. A Discounted ...

Simply Wall Street 2 weeks ago 0

Bearish

PATENT—Fed. Cir.: Validity of Teva Pharma’s migraine antibody patents reinstated, judgment for Eli Lilly reversed

The Federal Circuit has reinstated the validity of Teva Pharmaceutical's migraine antibody patents and reversed a judgment in favor of Eli Lilly. This...

VitalLaw.com 3 weeks ago 0

Bearish

Teva Pharmaceutical Industries Ltd (TEVA) Shares Surge 3.6% -- What GF Score of 54 Tells Investors

Teva Pharmaceutical Industries Ltd (TEVA) saw its shares surge by 3.6% to $32.40, marking a 137.4% increase over the past year. Despite this rise, Gur...

GuruFocus 3 weeks ago 0